Legend Biotech Corp (LEGN) Form 6-K — Oct 13, 2026

$LEGNForm 6-KFiled Oct 13, 2026, 7:30 AM ET0001171843-26-006593Original filing

Legend Biotech announced that CARVYKTI generated approximately $710 million in net trade sales during the quarter ended September 30, 2026, per its Form 6-K filed October 13, 2026. The sales figure was provided by collaboration partner Janssen under the December 2017 Collaboration and License Agreement and has not been independently verified by Legend Biotech.

Key figures

Revenue: $710 million in CARVYKTI net trade sales for the quarter ended September 30, 2026

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.